Clinical

Clinical  ·  Weekly Digest 10 to 16 Feb
Lantern Pharma progresses novel ADC program in various solid tumors

Weekly Digest – Feb 2024 Weekly Digest – Feb 2024 15 Feb 2024: Lantern Pharma progresses novel ADC program in various solid tumors Lantern has advanced the development, synthesis, and preclinical POC of a novel, highly potent, cryptophycin-based ADC The […]

by Sandhya Ramalingam

Continue Reading
Clinical  ·  Weekly Digest 10 to 16 Feb
Dragonfly and Gilead to Explore DF1001 HER-2 TriNKET with Trodelvy in Cancer

Weekly Digest – Feb 2024 Weekly Digest – Feb 2024 15 Feb 2024: Dragonfly and Gilead to Explore DF1001 HER-2 TriNKET with Trodelvy in Cancer Dragonfly Therapeutics has initiated a clinical collaboration to assess DF1001, a HER-2 immune engager developed […]

by Sandhya Ramalingam

Continue Reading